PAPER Parnetti L, Chiasserini D, Bellomo G, Giannandrea D, De Carlo C, Qureshi MM, Ardah MT, Varghese S, Bonanni L, Borroni B, Tambasco N, Eusebi P, Rossi A, Onofrj M, Padovani A, Calabresi P, El-Agnaf O

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.

Mov Disord. 2011 Jul;26(8):1428-35. Epub 2011 Apr 5 PubMed: 21469206

PAPER Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM

Plasma clusterin and the risk of Alzheimer disease.

JAMA. 2011 Apr 6;305(13):1322-6. PubMed: 21467285

Double Down: TDP-43 Fragments Bust Cells on Second Hit

RESEARCH NEWS 2011-04-07 Research News Clumped fragments of TAR DNA Binding Protein-43 appear to clog neurons in people with TDP-43 proteinopathies. Though it is not clear why, carboxy-terminal fragments of the normally nuclear protein wind up forming aggregates in the cytoplasm.

Barcelona: Parkinson’s Treatments on the Horizon

CONFERENCE COVERAGE 2011-04-07 Conference Coverage With effective symptomatic treatments in hand, many Parkinson’s researchers have now set their sights on loftier goals. Experimental treatments aim to restore lost brain function and arrest disease progression. Researchers are explorin

PAPER Ogaki K, Motoi Y, Li Y, Tomiyama H, Shimizu N, Takanashi M, Nakanishi A, Yokoyama K, Hattori N

Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): a comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with

Mov Disord. 2011 Feb 15;26(3):561-3. PubMed: 21462266

PAPER Picazo O, Espinosa-Raya J, Jiménez-Trejo F, Suarez J

Role of estrogens on some cognition-related aspects.

Curr Top Med Chem. 2011;11(13):1742-9. PubMed: 21463248

PAPER Köllensperger M, Krismer F, Pallua A, Stefanova N, Poewe W, Wenning GK

Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.

Mov Disord. 2011 Feb 15;26(3):507-15. PubMed: 21462262

PAPER Jaiswal A, Chhabra A, Malhotra U, Kohli S, Rani V

Comparative analysis of human matrix metalloproteinases: Emerging therapeutic targets in diseases.

Bioinformation. 2011;6(1):23-30. PubMed: 21464841

PAPER Kim SM, Kim H, Kim JE, Park KS, Sung JJ, Kim SH, Lee KW

Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice.

PLoS One. 2011;6(3):e17985. PubMed: 21464953

PAPER Zhou Z, Yuan Q, Mash DC, Goldman D

Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol.

Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6626-31. PubMed: 21464311

PAPER Panizzon MS, Lyons MJ, Jacobson KC, Franz CE, Grant MD, Eisen SA, Xian H, Kremen WS

Genetic architecture of learning and delayed recall: a twin study of episodic memory.

Neuropsychology. 2011 Jul;25(4):488-98. PubMed: 21463045

PAPER Domingues-Montanari S, Parés M, Hernández-Guillamon M, Fernández-Cadenas I, Mendioroz M, Ortega G, Boada M, Masjuan J, Huertas N, Alvarez-Sabín J, Delgado P, Montaner J,

No evidence of APP point mutation and locus duplication in individuals with cerebral amyloid angiopathy.

Eur J Neurol. 2011 Oct;18(10):1279-81. PubMed: 21463452

PAPER Misra S, Tiwari V, Kuhad A, Chopra K

Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats.

Eur J Pharmacol. 2011 Jun 1;659(2-3):177-86. PubMed: 21463622

PAPER Wallace TL, Ballard TM, Pouzet B, Riedel WJ, Wettstein JG

Drug targets for cognitive enhancement in neuropsychiatric disorders.

Pharmacol Biochem Behav. 2011 Aug;99(2):130-45. PubMed: 21463652

PAPER Kuester M, Kemmerzehl S, Dahms SO, Roeser D, Than ME

The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP).

J Mol Biol. 2011 Jun 3;409(2):189-201. PubMed: 21463639